Fund Holdings — Lynx1 Capital Management LP

Total Portfolio Value:
$254.32M
Total Bought:
$96.14M
Total Sold:
$19.01M
Net Transaction:
+$77.13M
Notable People:
Weston Agnew Nichols
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Alpine Immune Sciences Inc2,404,6143,813,926+1,409,312$27.53M$72.69M28.58%+$45.16M
Cabaletta Bio, Inc.(CABA)2,106,0002,110,401+4,401$32.05M$47.91M18.84%+$15.85M
Merus N V1,150,2251,135,225-15,000$27.12M$31.22M12.28%+$4.10M
TScan Therapeutics, Inc.(TCRX)5,224,6005,224,6000$13.37M$30.46M11.98%+$17.08M
C4 Therapeutics, Inc.(CCCC)1,019,2303,134,396+2,115,166$1.90M$17.71M6.96%+$15.81M
Stoke Therapeutics, Inc.(STOK)1,710,1542,956,918+1,246,764$6.74M$15.55M6.12%+$8.82M
Autolus Therapeutics plcADS(AUTL)1,363,0251,858,409+495,384$3.18M$11.97M4.71%+$8.79M
GH Research PLC(GHRS)1,103,1781,838,617+735,439$11.09M$10.66M4.19%-$423.0K
Kinnate Biopharma Inc1,997,0061,997,0060$2.80M$4.73M1.86%+$1.94M
Silence Therapeutics plcADS(SLN)235,787235,7870$2.32M$4.10M1.61%+$1.78M
Theseus Pharmaceuticals Inc702,415702,4150$1.89M$2.84M1.12%+$955.3K
Pieris Pharmaceuticals Inc9,775,8499,775,8490$2.91M$1.78M0.70%-$1.13M
Bionomics LimitedADS815,512824,305+8,793$2.20M$1.22M0.48%-$981.9K
Nektar Therapeutics(NKTR)1,766,8151,929,198+162,383$1.05M$1.09M0.43%+$37.7K
Passage Bio, Inc.(PASG)190,124379,159+189,035$125.1K$383.0K0.15%+$257.8K
CYMABAY THERAPEUTICS INCCOM994,1610-994,161$14.82M$0—-$14.82M
DBV TECHNOLOGIES S ASPONSORED ADR18,2650-18,265$24.8K$0—-$24.8K
ZURA BIO LTDCLASS A ORD SHS(ZURA)9,9170-9,917$65.5K$0—-$65.5K
Page 1 of 1
Lynx1 Capital Management LP — 13F Holdings — Q4 2023 | TickerTrail